Securities code: 688575 securities abbreviation: Shenzhen Yhlo Biotech Co.Ltd(688575) Announcement No.: 2022-018 Shenzhen Yhlo Biotech Co.Ltd(688575)
Announcement on the resolution of the fifth meeting of the third board of directors
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law. The fifth meeting of the third board of directors (hereinafter referred to as “the meeting”) of Shenzhen Yhlo Biotech Co.Ltd(688575) (hereinafter referred to as “the company”) was held on February 7, 2022 by means of on-site communication. There were 7 directors who should attend the meeting, and 7 directors actually attended, accounting for 100% of the number of directors who should attend. The convening and convening procedures of this meeting meet the requirements of the articles of association and relevant laws and regulations. After deliberation and voting by the directors present at the meeting, the following resolutions were reached at the meeting:
1、 The proposal on adjusting the incentive plan for restricted stocks in 2022 was deliberated and adopted
In accordance with the relevant provisions of the administrative measures for equity incentive of listed companies (hereinafter referred to as the “administrative measures”), the 2022 restricted stock incentive plan (Draft) (hereinafter referred to as the “incentive plan (Draft)”) and its summary, and the authorization of the company’s first extraordinary general meeting in 2022, As two incentive objects of the company’s 2022 restricted stock incentive plan (hereinafter referred to as “the incentive plan”) voluntarily give up the qualification and corresponding equity shares of the rights granted by the incentive plan due to personal reasons, the company plans to adjust the list of incentive objects and the number of rights granted for the first time in the incentive plan. After adjustment, the number of incentive objects granted for the first time in the company’s restricted stock incentive plan was adjusted from 65 to 63, the number of restricted shares granted for the first time was adjusted from 1658000 to 163300, and the number of restricted shares reserved for grant was adjusted from 342000 to 367000. For details, please refer to the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Announcement of Shenzhen Yhlo Biotech Co.Ltd(688575) on matters related to the adjustment of the restricted stock incentive plan in 2022 (Announcement No.: 2022-016) disclosed on the.
Independent directors expressed their independent opinions on the above proposal.
Voting result: 7 votes in favor; 0 votes against; There were no abstentions.
2、 The proposal on granting restricted shares to incentive objects for the first time was deliberated and adopted
According to the relevant provisions of the management measures, the incentive plan (Draft) and the authorization of the company’s first extraordinary general meeting in 2022, the board of Directors considers that the grant conditions specified in the company’s restricted stock incentive plan in 2022 have been met, and agrees to determine the first grant date on February 7, 2022, At the grant price of 16.00 yuan / share, 1633000 restricted shares were granted to 63 eligible incentive objects.
For details, please refer to the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Announcement of Shenzhen Yhlo Biotech Co.Ltd(688575) on granting restricted shares to incentive objects for the first time (Announcement No.: 2022-017) disclosed on the.
Independent directors expressed their independent opinions on the above proposal.
Voting result: 7 votes in favor; 0 votes against; There were no abstentions.
It is hereby announced.
Shenzhen Yhlo Biotech Co.Ltd(688575) board of directors February 8, 2022
